

Cover Story
Free
By Matthew Bin Han Ong
FDA's passive reliance on self-reporting by hospitals and device manufacturers allowed harm caused by power morcellators to go unnoticed for over two decades—likely contributing to injury and deaths of hundreds of women, according to the U.S. Government Accountability Office said.
In Brief
Funding Opportunities
Drugs & Targets
Trending Stories
- Trump backs off the 100% pharma tariffs ultimatum
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- Latinx oncology leaders talk about the impact of federal policy on cancer outcomes in Latinx communities
- ASCO and Google Cloud set forth a vision for using AI to modernize health care and advance oncology
- The insinuation that AstroTurf causes GBM has no basis in science
The Philadelphia Inquirer series does disservice to brain tumor community - Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research